Respiratory Immunopharmacology
31 – 40 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)
- Contribution to journal › Article
-
Mark
NFκB1 Dichotomously Regulates Pro-Inflammatory and Antiviral Responses in Asthma
- Contribution to journal › Article
-
Mark
Association of rhinitis with asthma prevalence and severity
- Contribution to journal › Article
- 2021
-
Mark
Imaging biomarkers in animal models of drug-induced lung injury : A systematic review
- Contribution to journal › Scientific review
-
Mark
Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment
(2021) European Respiratory Society (ERS) congress 2021
- Contribution to conference › Poster
-
Mark
Efficacy of mepolizumab in usual clinical practice and characteristics of responders : Mepolizumab in usual clinical practice
- Contribution to journal › Article
-
Mark
Mast cell tryptase enhances wound healing by promoting migration in human bronchial epithelial cells
- Contribution to journal › Article
-
Mark
Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection
- Contribution to journal › Article
-
Mark
Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses
- Contribution to journal › Article
-
Mark
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma
- Contribution to journal › Article
